Brief: BB Biotech Reports Q3 2026 Net Profit CHF 175 Mln

Bb Biotech AG

Today 06:03

Oct 23 (Reuters) - BB BIOTECH AG BION.S:
Q3 2026 NAV RETURNED 5.6% IN CHF; SHARE PRICE RETURNED 6.5% IN CHF
Q3 2026 NET PROFIT AMOUNTED TO CHF 175 MILLION
SEES SELECTIVE OPPORTUNITIES IN COMPANIES WHOSE SHARE PRICES HAVE FALLEN WITHOUT A CORRESPONDING CHANGE IN THEIR CLINICAL PROSPECTS
Source text: ID:nEQ5T5pZpa
Further company coverage: BION.S

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))